The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
One of the neuropathological hallmarks of Alzheimer's disease is the neurofibrillary tangle, which contains paired helical filaments (PHFs) composed of the microtubule-associated protein tau. Tau is hyperphosphorylated in PHFs, and phosphorylation of tau abolishes its ability to bind microtubules and promote microtubule assembly. Restoring the function of phosphorylated tau might prevent or reverse PHF formation in Alzheimer's disease. Phosphorylation on a serine or threonine that precedes proline (pS/T-P) alters the rate of prolyl isomerization and creates a binding site for the WW domain of the prolyl isomerase Pin1. Pin1 specifically isomerizes pS/T-P bonds and regulates the function of mitotic phosphoproteins. Here we show that Pin1 binds to only one pT-P motif in tau and copurifies with PHFs, resulting in depletion of soluble Pin1 in the brains of Alzheimer's disease patients. Pin1 can restore the ability of phosphorylated tau to bind microtubules and promote microtubule assembly in vitro. As depletion of Pin1 induces mitotic arrest and apoptotic cell death, sequestration of Pin1 into PHFs may contribute to neuronal death. These findings provide a new insight into the pathogenesis of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is also growing evidence for the association between DNA damage and increased expression of cell-cycle markers in AD [34], [38].”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [38]
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationMutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,112
Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17
Hong, M. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,003
A human peptidyl–prolyl isomerase essential for regulation of mitosis
Ping Lu, K., Hanes, S. D., & Hunter, T. (1996) · Nature · doi:10.1038/380544a0 · Cited by 904
Self-citationBramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Yaffe, M. B., Schutkowski, M., Shen, M., Zhou, X. Z., Stukenberg, P. T., Rahfeld, J.-U., Xu, J., Kuang, J., Kirschner, M. W., Fischer, G., et al. (1997) · Science · doi:10.1126/science.278.5345.1957 · Cited by 770
Self-citationRole of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.
Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738
Ranganathan, R., Lu, K. P., Hunter, T., & Noel, J. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80273-1 · Cited by 699
Self-citation
Cited by
Items 101–200 of 724
Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein
Wen, Y., Yang, S., Liu, R., & Simpkins, J. W. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.106 · Cited by 156
Min, S.-H., Lau, A. W., Lee, T. H., Inuzuka, H., Wei, S., Huang, P., Shaik, S., Lee, D. Y., Finn, G., Balastik, M., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.012 · Cited by 147
Self-citationKatsumoto, A., Takeuchi, H., & Tanaka, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00980 · Cited by 166
Advances in Alzheimer’s Diagnosis and Therapy: The Implications of Nanotechnology
Hajipour, M. J., Santoso, M. R., Rezaee, F., Aghaverdi, H., Mahmoudi, M., & Perry, G. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2017.06.002 · Cited by 143
Avila, J., Jiménez, J. S., Sayas, C. L., Bolós, M., Zabala, J. C., Rivas, G., & Hernández, F. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00262 · Cited by 140
“As indicated, T231 can be phosphorylated and the following prolines can have a cis or trans conformation which could regulate the posterior dephosphorylation of P-T231 (Lu et al., 1999).”
BackgroundWen, Y., Yang, S., Liu, R., Brun-Zinkernagel, A. M., Koulen, P., & Simpkins, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311768200 · Cited by 142
Oliver, P. M., Cao, X., Worthen, G. S., Shi, P., Briones, N. J., MacLeod, M. K. L., White, J., Kirby, P., Kappler, J. W., Marrack, P., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.012 · Cited by 142
Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism
Zhou, X. Z., Lu, P., Wulf, G. M., & Lu, K. P. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050026 · Cited by 158
Self-citationMolecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease
Lloret, A., Fuchsberger, T., Giraldo, E., & Viña, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.028 · Cited by 135
Tau Aggregation and Toxicity in a Cell Culture Model of Tauopathy
Bandyopadhyay, B., Li, G., Yin, H., & Kuret, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700192200 · Cited by 133
The hunchback and its neighbours: proline as an environmental modulator
Reiersen, H., & Rees, A. R. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01957-0 · Cited by 154
1H NMR Study on the Binding of Pin1 Trp-Trp Domain with Phosphothreonine Peptides
Wintjens, R., Wieruszeski, J.-M., Drobecq, H., Rousselot-Pailley, P., Buée, L., Lippens, G., & Landrieu, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010327200 · Cited by 131
Down-regulation of WW Domain-containing Oxidoreductase Induces Tau Phosphorylation in Vitro
Sze, C.-I., Su, M., Pugazhenthi, S., Jambal, P., Hsu, L.-J., Heath, J., Schultz, L., & Chang, N.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401399200 · Cited by 130
“Prion‐Like” Templated Misfolding in Tauopathies
Clavaguera, F., Lavenir, I., Falcon, B., Frank, S., Goedert, M., & Tolnay, M. (2013) · Brain Pathology · doi:10.1111/bpa.12044 · Cited by 130
Dunyak, B. M., & Gestwicki, J. E. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00411 · Cited by 139
Shen, Z.-J., Esnault, S. J., & Malter, J. S. (2005) · Nature Immunology · doi:10.1038/ni1266 · Cited by 138
Amit, T., Avramovich‐Tirosh, Y., Youdim, M. B. H., & Mandel, S. (2008) · The FASEB Journal · doi:10.1096/fj.07-8627rev · Cited by 126
Butterfield, D. A., & Sultana, R. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-12107 · Cited by 126
Rippmann, J. F., Hobbie, S., Daiber, C., Guilliard, B., Bauer, M., Birk, J., Nar, H., Garin‐Chesa, P., Rettig, W. J., & Schnapp, A. (2000) · PubMed · Cited by 126
Alvarez, A. R., Muñoz, J. P., & Maccioni, R. B. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5152 · Cited by 138
Butterfield, D. A., Reed, T., & Sultana, R. (2011) · Free Radical Research · doi:10.3109/10715762.2010.520014 · Cited by 123
Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics
Lu, K. P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00218-6 · Cited by 123
Self-citationWW domain-containing proteins: Retrospectives and the future
Salah, Z. (2012) · Frontiers in Bioscience · doi:10.2741/3930 · Cited by 121
Blair, L. J., Baker, J. D., Sabbagh, J. J., & Dickey, C. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13033 · Cited by 120
Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer’s disease
Yang, Y., Tapias, V., Acosta, D., Xu, H., Chen, H., Bhawal, R., Anderson, E. T., Ivanova, E., Lin, H., Sagdullaev, B. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27572-2 · Cited by 118
Tau Phosphorylation by GSK3 in Different Conditions
Avila, J., León-Espinosa, G., García, E., García-Escudero, V., Hernández, F., & DeFelipe, J. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/578373 · Cited by 117
Disease modifying therapy for AD?1
Golde, T. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04211.x · Cited by 117
Targeting Hsp90 and its co-chaperones to treat Alzheimer’s disease
Blair, L. J., Sabbagh, J. J., & Dickey, C. A. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.943185 · Cited by 117
Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy
Lim, J., Balastik, M., Lee, T. H., Nakamura, K., Liou, Y.-C., Sun, A., Finn, G., Pastorino, L., Lee, V. M.-Y., & Lu, K. P. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34308 · Cited by 116
Self-citationPérez, M., Cuadros, R., Smith, M. A., Perry, G., & Avila, J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02323-1 · Cited by 116
Tau as a therapeutic target in neurodegenerative disease
Himmelstein, D. S., Ward, S. M., Lancia, J. K., Patterson, K. R., & Binder, L. I. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.001 · Cited by 115
Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance
Lee, T. H., Tun-Kyi, A., Shi, R., Lim, J., Soohoo, C., Finn, G., Balaštík, M., Pastorino, L., Wulf, G. M., Zhou, X. Z., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1818 · Cited by 124
Self-citationPhospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy
Kimura, T., Sharma, G., Ishiguro, K., & Hisanaga, S.-I. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00044 · Cited by 114
Phosphorylation Signaling in APP Processing in Alzheimer’s Disease
Zhang, T., Chen, D., & Lee, T. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010209 · Cited by 112
Sadik, G., Tanaka, T., Kato, K., Yamamori, H., Nessa, B. N., Morihara, T., & Takeda, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05716.x · Cited by 114
Telomeric Protein Pin2/TRF1 as an Important ATM Target in Response to Double Strand DNA Breaks
Kishi, S., Zhou, X. Z., Ziv, Y., Khoo, C., Hill, D. E., Shiloh, Y., & Lu, K. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011534200 · Cited by 111
Self-citationPharmacogenomics in Alzheimer's Disease
Cacabelos, R. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-205-2_10 · Cited by 109
Molecular crosstalk between cancer and neurodegenerative diseases
Seo, J., & Park, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03428-3 · Cited by 113
Protein aggregation as a paradigm of aging
Lindner, A. B., & Démarez, A. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.06.005 · Cited by 127
Mitotic-like Tau Phosphorylation by p25-Cdk5 Kinase Complex
Hamdane, M., Sambo, A.-V., Delobel, P., Bégard, S., Violleau, A., Delacourte, A., Bertrand, P., Benavides, J., & Buée, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302872200 · Cited by 107
Arevalo-Rodriguez, M. (2004) · Frontiers in Bioscience · doi:10.2741/1405 · Cited by 106
Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease
Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105
Shen, Z.-J., Esnault, S., Schinzel, A., Borner, C., & Malter, J. S. (2009) · Nature Immunology · doi:10.1038/ni.1697 · Cited by 105
Interactions between Protein Kinase CK2 and Pin1
Messenger, M. M., Saulnier, R. B., Gilchrist, A. D., Diamond, P., Gorbsky, G. J., & Litchfield, D. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200111200 · Cited by 104
Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment
Garg, S., Timm, T., Mandelkow, E.-M., Mandelkow, E., & Wang, Y. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.008 · Cited by 103
PIN1 promoter polymorphisms are associated with Alzheimer's disease
Segat, L., Pontillo, A., Annoni, G., Trabattoni, D., Vergani, C., Clerici, M., Arosio, B., & Crovella, S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.11.009 · Cited by 109
Silva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099897 · Cited by 99
“Regarding nuclear staining, pyramidal neurons from the hippocampus of CP-AD individuals demonstrated higher expression levels of Cdk4, cyclin D, phospho-Rb, E2F1, Cdk1, and cyclin B than did those from either P-AD or N subjects (Figure 3A, 3C, 3E, 3G, 3I, and 3K; Table 4; Figures S9–S14).”
BackgroundInfluentialNeuronal intermediate filaments and neurodegenerative disorders
Perrot, R., & Eyer, J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.004 · Cited by 125
Hu, Z., Chen, P.-H., Li, W., Douglas, T., Hines, J., Liu, Y., & Crews, C. M. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11706 · Cited by 98
Tau as a Therapeutic Target for Alzheimers Disease
Boutajangout, A., M. Sigurdsson, E., & K. Krishnamurthy, P. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717195 · Cited by 97
Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease
Hanger, D. P., Seereeram, A., & Noble, W. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.104 · Cited by 98
Kim, B. M., You, M.-H., Chen, C.-H., Lee, S., Hong, Y., Hong, Y., Kimchi, A., Zhou, X. Z., & Lee, T. H. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.216 · Cited by 98
Self-citationGalas, M.-C., Dourlen, P., Bégard, S., Ando, K., Blum, D., Hamdane, M., & Buée, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601849200 · Cited by 97
Sottejeau, Y., Bretteville, A., Cantrelle, F.-X., Malmanche, N., Demiaute, F., Mendes, T., Delay, C., Alves Dos Alves, H., Flaig, A., Davies, P., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0237-8 · Cited by 98
“The enzymes that control this phosphorylation (such as Cdk5 [22], Gsk3-β [23], PP2A [24] and PIN1 [25]) are markedly deregulated during the AD process.”
Self-citationChen, C.-H., Li, W., Sultana, R., You, M.-H., Kondo, A., Shahpasand, K., Kim, B. M., Luo, M.-L., Nechama, M., Lin, Y.-M., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.027 · Cited by 96
Self-citationPhosphorylation mechanisms in dopamine transporter regulation
Foster, J. D., & Vaughan, R. A. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.10.004 · Cited by 102
Nechama, M., Uchida, T., Levi, I. M.-Y., Silver, J., & Naveh‐Many, T. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39522 · Cited by 96
The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
Wolfe, M. S. (2012) · Scientifica · doi:10.6064/2012/796024 · Cited by 96
Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2.
Wijsman, E. M., Daw, E. W., Yu, C.-E., Payami, H., Steinbart, E. J., Nochlin, D., Conlon, E. M., Bird, T. D., & Schellenberg, G. D. (2004) · The American Journal of Human Genetics · doi:10.1086/423393 · Cited by 71
ATR Plays a Direct Antiapoptotic Role at Mitochondria, which Is Regulated by Prolyl Isomerase Pin1
Hilton, B. A., Li, Z., Musich, P. R., Wang, H., Cartwright, B. M., Serrano, M., Zhou, X. Z., Lu, K. P., & Zou, Y. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.008 · Cited by 95
Self-citationTau aggregation into fibrillar polymers: taupathies
Avila, J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01676-8 · Cited by 94
Mandelkow�, E. (1999) · Nature · doi:10.1038/45095 · Cited by 95
The cell cycle as a therapeutic target for Alzheimer's disease
Neve, R. L., & McPhie, D. L. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.005 · Cited by 92
Wang, L., Bharti, Kumar, R., Pavlov, P. F., & Winblad, B. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112915 · Cited by 92
Pin1 in Alzheimer's disease: Multiple substrates, one regulatory mechanism?
Balaštík, M., Lim, J., Pastorino, L., & Lu, K. P. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.01.006 · Cited by 100
Self-citationLin, Y., Cheng, J., Liang, L., Ko, C., Lo, Y., & Lu, P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04792.x · Cited by 89
Self-citationFunctionally Important Residues in the Peptidyl-prolyl Isomerase Pin1 Revealed by Unigenic Evolution
Behrsin, C. D., Bailey, M. L., Bateman, K., Hamilton, K. S., Wahl, L. M., Brandl, C. J., Shilton, B. H., & Litchfield, D. W. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.078 · Cited by 90
Proline‐directed phosphorylation and isomerization in mitotic regulation and in Alzheimer's Disease
Lu, K. P., Liou, Y., & Vincent, I. (2003) · BioEssays · doi:10.1002/bies.10223 · Cited by 89
Self-citationIshizawa, T., Sahara, N., Ishiguro, K., Kersh, J. S., McGowan, E. M., Lewis, J. M., Hutton, M. L., Dickson, D. W., & Yen, S.-H. C. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63465-7 · Cited by 99
Targeting Aβ and tau in Alzheimer's disease, an early interim report
Golde, T. E., Petrucelli, L., & Lewis, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.035 · Cited by 89
“For example, there is no known way to pharmacologically activate or increase expression of Pin1, which is an attractive target that has been reported to isomerize phosphorylated tau and restores the ability of phosphorylated tau to bind microtubules, and eventually promote dephosphorylation of tau by PP2A phosphatase…”
Moussa, N., & Dayoub, N. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.101729 · Cited by 102
Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease
Driver, J. A., Zhou, X. Z., & Lu, K. P. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.12.025 · Cited by 88
Self-citationSultana, R., Reed, T., Perluigi, M., Coccia, R., Pierce, W. M., & Butterfield, D. A. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00065.x · Cited by 87
Dujardin, S., Colin, M., & Buée, L. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12200 · Cited by 87
Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology
Köhler, C. N. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1562-0 · Cited by 91
Del Prete, D., Rice, R. C., Rajadhyaksha, A. M., & D'Adamio, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.733626 · Cited by 86
Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease
Harris, R. A., Tindale, L. C., & Cumming, R. C. (2014) · Biogerontology · doi:10.1007/s10522-014-9534-z · Cited by 90
Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus
Holzer, M., Gärtner, U., Stöbe, A., Härtig, W., Gruschka, H., Brückner, M. K., & Arendt, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0581-1 · Cited by 90
A nuclear FK506-binding protein is a histone chaperone regulating rDNA silencing
Kuzuhara, T., & Horikoshi, M. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb733 · Cited by 93
Ma, S. L., Pastorino, L., Zhou, X. Z., & Lu, K. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c111.298596 · Cited by 88
Self-citationThe role of tau in Alzheimer's disease
Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00002-0 · Cited by 85
Ryo, A., Togo, T., Nakai, T., Hirai, A., Nishi, M., Yamaguchi, A., Suzuki, K., Hirayasu, Y., Kobayashi, H., Perrem, K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507026200 · Cited by 85
Pin1 and PKMζ Sequentially Control Dendritic Protein Synthesis
Westmark, P. R., Westmark, C. J., Wang, S., Levenson, J., O’Riordan, K. J., Burger, C., & Malter, J. S. (2010) · Science Signaling · doi:10.1126/scisignal.2000451 · Cited by 84
Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies
Ramakrishnan, P., Dickson, D. W., & Davies, P. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00109-8 · Cited by 85
Self-citationSultana, R., & Butterfield, D. A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129018 · Cited by 83
Pin1 allows for differential Tau dephosphorylation in neuronal cells
Hamdane, M., Dourlen, P., Bretteville, A., Sambo, A., Ferreira, S., Ando, K., Kerdraon, O., Bégard, S., Geay, L., Lippens, G. M., et al. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.03.006 · Cited by 86
Protein Phosphorylation is a Key Mechanism in Alzheimer’s Disease
Oliveira, J., Costa, M., de Almeida, M. S. C., da Cruz e Silva, O. A. B., & Henriques, A. G. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170176 · Cited by 80
The FTDP‐17‐Linked Mutation R406W Abolishes the Interaction of Phosphorylated Tau with Microtubules
Pérez, M., Lim, F., Arrasate, M., & Avila, J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742583.x · Cited by 80
The Peptidyl-prolyl Isomerase Pin1 Up-regulation and Proapoptotic Function in Dopaminergic Neurons
Ghosh, A., Saminathan, H., Kanthasamy, A., Anantharam, V., Jin, H., Sondarva, G. V., Harischandra, D. S., Qian, Z., Rana, A., & Kanthasamy, A. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.444224 · Cited by 88
Grison, A., Mantovani, F., Comel, A., Agostoni, E., Gustincich, S., Persichetti, F., & Del Sal, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106198108 · Cited by 73
Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies
Venkatramani, A., & Panda, D. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.04.120 · Cited by 78
Two pathways mediate interdomain allosteric regulation in pin1
Guo, J., Pang, X., & Zhou, H.-X. (2015) · Structure · doi:10.1016/j.str.2014.11.009 · Cited by 78
“Pin1 dysregulation is implicated in various diseases, including cancer and Alzheimer’s disease (Lu, 2004; Lu and Zhou, 2007; Lu et al., 1999b; Wulf et al., 2001).”
BackgroundInfluentialPhosphorylation of Human Tau Protein by Microtubule Affinity-Regulating Kinase 2
Schwalbe, M., Biernat, J., Bibow, S., Ozenne, V., Jensen, M. R., Kadavath, H., Blackledge, M., Mandelkow, E., & Zweckstetter, M. (2013) · Biochemistry · doi:10.1021/bi401266n · Cited by 78
Eroglu, B., Moskophidis, D., & Mivechi, N. F. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01493-09 · Cited by 91
Peptidyl‐prolyl isomerase inhibitors
Wang, X. J., & Etzkorn, F. A. (2006) · Peptide Science · doi:10.1002/bip.20240 · Cited by 78
Accumulation of nuclear ADAR2 regulates adenosine-to-inosine RNA editing during neuronal development
Behm, M., Wahlstedt, H., Widmark, A., Eriksson, M., & Öhman, M. (2017) · Journal of Cell Science · doi:10.1242/jcs.200055 · Cited by 79
Johnson, G. V. W., & Bailey, C. D. C. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4505 · Cited by 61
LaFevre-Bernt, M. A., & Ellerby, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302841200 · Cited by 78
Rajbhandari, P., Finn, G., Solodin, N. M., Singarapu, K. K., Sahu, S. C., Markley, J. L., Kadunc, K. J., Ellison-Zelski, S. J., Kariagina, A., Haslam, S. Z., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06073-11 · Cited by 77
Self-citationThe prolyl isomerase Pin1 in breast development and cancer
Wulf, G., Ryo, A., Liou, Y.-C., & Ping Lu, K. (2003) · Breast Cancer Research · doi:10.1186/bcr572 · Cited by 77
Self-citation
Metadata
- Authors
- Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Lu, Kun Ping
- Venue
- Nature
- Published
- 1999-06
- Volume
- 399
- Issue
- 6738
- Pages
- 784-788
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1541944730
- Cited by
- 721
- References
- 30
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 22 · 2023: 26 · 2022: 20 · 2021: 18 · 2020: 20 · 2019: 23 · 2018: 34 · 2017: 25 · 2016: 28 · 2015: 36 · 2014: 31 · 2013: 37 · 2012: 37
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Pin1, peptidyl-prolyl isomerase, tau phosphorylation, Alzheimer's disease, neurofibrillary tangles, paired helical filaments, microtubule binding, microtubule assembly, WW domain, mitotic arrest, neuronal apoptosis, protein depletion
- MeSH terms
- NIMA-Interacting Peptidylprolyl Isomerase, Alzheimer Disease, Amino Acid Sequence, Animals, Binding Sites, Brain, Glutathione Transferase, Humans, Microtubules, Mitosis, Molecular Sequence Data, Phosphorylation, Protein Binding, Recombinant Fusion Proteins, Xenopus, tau Proteins, Apoptosis, Peptidylprolyl Isomerase, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.